Researchers showed that HematoMiRs and their combinations targeting over 50 factors involved in HSC quiescence could induce robust ex vivo murine and human HSC expansion. In particular, HematoMiR-5 treatment enhanced cell cycle through down-regulation of negative cell cycle regulators in HSCs.
[Cellular and Molecular Life Sciences]
Sorry, but the selected Zotpress account can't be found.